These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8485049)

  • 1. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer.
    Gastl G; Plante M; Finstad CL; Wong GY; Federici MG; Bander NH; Rubin SC
    Br J Haematol; 1993 Mar; 83(3):433-41. PubMed ID: 8485049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis.
    Hsu HC; Tsai WH; Jiang ML; Ho CH; Hsu ML; Ho CK; Wang SY
    J Lab Clin Med; 1999 Oct; 134(4):392-7. PubMed ID: 10521086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis.
    Hollen CW; Henthorn J; Koziol JA; Burstein SA
    Br J Haematol; 1991 Oct; 79(2):286-90. PubMed ID: 1958487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts.
    van der Zee AG; de Cuyper EM; Limburg PC; de Bruijn HW; Hollema H; Bijzet J; Krans M; de Vries EG
    Cancer; 1995 Feb; 75(4):1004-9. PubMed ID: 7842401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer.
    Plante M; Rubin SC; Wong GY; Federici MG; Finstad CL; Gastl GA
    Cancer; 1994 Apr; 73(7):1882-8. PubMed ID: 8137215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of thrombocytosis in ovarian cancer.
    Słabuszewska-Jóźwiak A; Dmoch-Gajzlerska E; Kozakiewicz B; Jakiel G
    Ann Agric Environ Med; 2015; 22(4):731-5. PubMed ID: 26706987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer.
    Gastl G; Plante M
    Methods Mol Med; 2001; 39():121-3. PubMed ID: 21340762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
    Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
    Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of serum and ascitic IL-12 levels with second-look laparotomy results and disease progression in advanced epithelial ovarian cancer patients.
    Bozkurt N; Yuce K; Basaran M; Gariboglu S; Kose F; Ayhan A
    Int J Gynecol Cancer; 2006; 16(1):83-6. PubMed ID: 16445615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
    Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IL-10 in patients with ovarian carcinoma.
    Mustea A; Könsgen D; Braicu EI; Pirvulescu C; Sun P; Sofroni D; Lichtenegger W; Sehouli J
    Anticancer Res; 2006; 26(2C):1715-8. PubMed ID: 16617566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic thrombocytosis in ovarian cancer.
    Stone RL; Nick AM; McNeish IA; Balkwill F; Han HD; Bottsford-Miller J; Rupairmoole R; Armaiz-Pena GN; Pecot CV; Coward J; Deavers MT; Vasquez HG; Urbauer D; Landen CN; Hu W; Gershenson H; Matsuo K; Shahzad MM; King ER; Tekedereli I; Ozpolat B; Ahn EH; Bond VK; Wang R; Drew AF; Gushiken F; Lamkin D; Collins K; DeGeest K; Lutgendorf SK; Chiu W; Lopez-Berestein G; Afshar-Kharghan V; Sood AK
    N Engl J Med; 2012 Feb; 366(7):610-8. PubMed ID: 22335738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis.
    Estrov Z; Talpaz M; Mavligit G; Pazdur R; Harris D; Greenberg SM; Kurzrock R
    Am J Med; 1995 Jun; 98(6):551-8. PubMed ID: 7539977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.
    Santin AD; Bellone S; Ravaggi A; Roman J; Smith CV; Pecorelli S; Cannon MJ; Parham GP
    BJOG; 2001 Aug; 108(8):804-8. PubMed ID: 11510703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma.
    Xie X; Ye D; Chen H; Lu W; Cheng B; Zhong H
    Int J Gynaecol Obstet; 2004 May; 85(2):151-8. PubMed ID: 15099777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of thrombocytosis in patients with epithelial ovarian cancer.
    Zeimet AG; Marth C; Müller-Holzner E; Daxenbichler G; Dapunt O
    Am J Obstet Gynecol; 1994 Feb; 170(2):549-54. PubMed ID: 8116711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
    Zhou JW; Cheng Q; Xie X; Chen HZ; Ye DF; Lu WG
    Ai Zheng; 2004 May; 23(5):573-6. PubMed ID: 15142457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of soluble interleukin-2 receptor-alpha are elevated in serum and ascitic fluid from epithelial ovarian cancer patients.
    Hurteau JA; Simon HU; Kurman C; Rubin L; Mills GB
    Am J Obstet Gynecol; 1994 Mar; 170(3):918-28. PubMed ID: 8141226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-6 levels in patients with thrombocytosis.
    Hollen CW; Henthorn J; Koziol JA; Burstein SA
    Leuk Lymphoma; 1992 Oct; 8(3):235-41. PubMed ID: 1490150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival.
    Menczer J; Schejter E; Geva D; Ginath S; Zakut H
    Eur J Gynaecol Oncol; 1998; 19(1):82-4. PubMed ID: 9476067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.